The Best Signal on the AI IPO Wave in 2026: What Polymarket's Anthropic Odds Reveal

Market data as of October 29, 2026. Prediction-market odds are crowd-priced expectations, not forecasts of fact, and they can move sharply in hours.

If you've watched Anthropic's IPO odds on X this week, you probably want to know two things. Is the listing as locked in as the numbers suggest? And what does the pricing say about the AI and SaaS market you build on, buy from, or raise money in?

The short answer: betting markets put the odds of an Anthropic IPO by December 31, 2026 at 95%. Traders now treat a 2026 listing as close to a foregone conclusion. The open questions are which week and at what price. Those two questions are where the useful signal sits. The timing contracts are volatile and thinly traded. The valuation contracts have already moved down from the most bullish scenario. Next to the IPO markets, a separate "best AI model" market just turned against Anthropic.

Bottom line (as of Oct 29, 2026):

- Polymarket traders currently price a 95% chance Anthropic IPOs by Dec 31, 94% by Dec 15, 88% by Nov 30, 60% by Nov 20, 2% by Nov 15, and 0% by Oct 31^[1].

- The implied listing window is mostly Nov 16–30, with roughly 58 points of probability between Nov 15 and Nov 20.

- The market has high confidence that a listing happens and much less agreement on valuation, timing precision, or Anthropic's model leadership. Those three are separate bets.

What Do the Polymarket "Anthropic IPO by __?" Odds Actually Say?

As of October 29, 2026, about $6,078,802 has been traded on Polymarket's "Anthropic IPO by __?" market, which resolves around January 1, 2027^[1]. The contract ladder reads:

Read the table as a cumulative curve. You can estimate the probability that the IPO lands in each window by subtracting adjacent contracts:

• Nov 15–20: roughly 58 points. This is the single most likely window in the market's view.
• Nov 20–30: roughly 28 points.
• Dec 1–31: roughly 7 points.
• Not in 2026 at all: roughly 5 points.

That sharp jump between the earlier and later dates is the story. Traders are not betting on whether the IPO happens. They are betting on which week the bankers price it. CNBC reported on October 26 that prediction markets viewed a 2026 Anthropic IPO as "near-certain"^[8]. Reuters reported two days later that these bets were "setting the tone" for the offering^[9].

The volume is uneven, and that matters. The Oct 31 and Dec 31 contracts hold close to $3M combined. The Nov 20 contract, which carries the most interesting signal, has under $65K. Much of that $6M sits on contracts at the extremes, where outcomes are close to settled.

Why Do Traders Treat the Anthropic IPO as Near-Certain?

The odds rest on a concrete regulatory filing. Anthropic filed its S-1 with the SEC on October 26, 2026^[2]. It plans to list on Nasdaq under the ticker ANT^[6]. The prospectus reports $16.3 billion in revenue for the first half of 2026^[6]. Reuters describes that as explosive growth paired with staggering costs^[4].

Once a company files publicly, the IPO stops being something to speculate about and becomes an execution timeline. Companies rarely file a public S-1 without intending to price, and they rarely pull one without a market shock. That explains most of why the Dec 31 contract is near 95% and not 70%.

The timing assumptions on X match the pricing on the curve:

A mid-November target fits the market's 58-point concentration in the Nov 15–20 window. It also explains why traders still hold some probability in reserve for late November and December. The S-1 leaves share count and price blank, which is standard at this stage. Those blanks are the remaining steps where delays can happen: the price range amendment, the roadshow, and the final pricing.

Why Do the November Contracts Swing So Hard?

The Nov 20 contract is the most fragile part of the market. On October 29 it sits near 60%^[1], but earlier this week it was printing much higher:

A 37-point move on about $50K is what a thin order book looks like. One motivated trader, or one rumor about roadshow dates, can move the price by a third. Compare that with the Dec 31 contract, where $1.45M of volume makes a similar swing far more expensive to force. The more volume behind a price, the more weight it deserves. The Nov 20 price tells you that traders lean toward mid-November and disagree about it. It does not tell you much more than that.

There is also a real mechanical reason to hedge on the exact date. Practitioners on X are pointing to it:

This is a fair technical point, and the post itself says it isn't legal advice. If the S-1's reviewed financials end in June, a listing that slips far enough could require the company to refresh its financial statements. That means more audit work and more SEC back-and-forth, which pushes the date later. Benzinga's day-one coverage likewise treats the timing and the opening price as the variables still in play^[10].

What developers and founders should take from this: separate "will IPO" from "will IPO by date X." The first is close to settled in the market's eyes. The second is a coin flip on specific weeks. If any of your plans depend on the listing date, such as an enterprise contract renewal, a secondary sale, or a competitive raise, assume the window could slip by weeks.

Is Anthropic Worth $1.5 Trillion or $2 Trillion?

This is where traders show real doubt. Polymarket runs separate contracts on Anthropic's listing valuation, and those have repriced lower:

A Reuters report that some investors were considering a $1.5T valuation, below earlier $2T talk, was enough to cut 19 points in a week. A separate contract asking whether Anthropic prices or closes above $2T has sat in the mid-40s:

The anchor point is Anthropic's last private round. In May 2026 it raised $65 billion at a $965 billion valuation^[15][14]. Going from there to a $1.5T–$2T public valuation in about six months requires investors to believe the growth curve continues. The most-cited independent estimate came from NYU valuation professor Aswath Damodaran:

Damodaran's ~$1.475T figure lands close to where the valuation contracts have moved. His range is very wide, from negative $373B to $4.04T. That spread is the most honest summary of the situation: the value depends almost entirely on assumptions about 2036 revenue and margins that nobody can verify today. The S-1 itself asks investors to see AI as a pivotal historical moment and not just a financial return, which tends to make skeptics more skeptical^[9].

Why this matters for SaaS buyers: the market is pushing back on the highest valuation scenarios. When a sophisticated crowd prices the top-end AI story at below even odds, treat vendor roadmap promises with the same caution. Strong demand and a justified price are different things.

What Does the S-1 Admit About Losses, Security Incidents, and Catastrophic Risk?

Much of the X discussion focuses on revenue, but the filing also discloses heavy losses. Reuters and Bloomberg both report enormous costs alongside the growth^[4][3]. Commentators cite a first-half net loss of roughly $80.7 billion against $16.3B in revenue, with Q2 showing a first operating profit. The filing also discloses AI security incidents and training delays as material risks^[3].

The PolicyEdge framing is the right lens for anyone doing procurement or compliance work. Observed model behavior, testing conditions, and business risk are three different categories. An incident found during red-teaming in a controlled environment is not evidence of a production failure. A month-plus training delay is a business risk because it can slow model releases, but it says nothing about whether the model is safe. When you read an S-1's risk factors, keep the categories separate:

1. What happened (incidents, delays)
2. Under what conditions (testing vs. deployment)
3. What it could cost (revenue, reputation, regulatory exposure)

Then there is the line that drew the most attention:

The post is pointed, but the tension it describes is real. Risk-factor sections are written to be broad. Lawyers list remote scenarios so the company can't be accused of hiding them later. Even so, an AI lab putting catastrophic-risk language into a securities filing is unusual. For enterprise buyers, it is worth bringing up in vendor due diligence: if the vendor names this risk in front of the SEC, your AI governance review can reasonably ask how it is mitigated.

Can Anthropic Win the IPO Race While Losing the Model Race?

This week showed that prediction markets can price two separate questions about the same company very differently. While IPO odds held near 95%, Polymarket's "best AI model by end of 2026" market moved sharply against Anthropic after Google released Gemini 4 Carbon:

The move was larger across the full set of time horizons:

Anthropic fell from 53.5% to 40% for end-of-2026 in three days. Other trackers show the same level:

Two points matter. First, as @en0rmity notes, this market resolves on the LMArena leaderboard on Dec 31, which is built from crowd preference votes and not enterprise benchmarks. It measures how much users like the answers, not coding reliability or uptime. Second, IPO odds and model-leadership odds are tied to different fundamentals. The IPO depends on revenue and the window for capital markets. The leaderboard depends on the next model release. The FT describes the filing as the start of Anthropic's IPO "countdown"^[5]. That countdown does not depend on topping a leaderboard by December.

The two markets meet at customer concentration. Damodaran's analysis notes that 1,900 companies now spend $1M+ a year on Claude, up from under 100 a year earlier, while the top five customers bring in about 25% of revenue. A strong enterprise base mixed with that much concentration means a model-quality shift that moves even one large customer would show up in the numbers. That is why competitive repricing can serve as an early warning that SaaS buyers and investors should track alongside the IPO odds.

What Does the $417B Compute Commitment Mean for SaaS Buyers?

Every valuation scenario depends on capital intensity. Bloomberg reports that the filing reveals about $417 billion in future AI spending commitments^[7]. Damodaran's summary cites a $600B+ figure for compute commitments, which likely reflects a different definition or scope. Either way, the scale is beyond what any SaaS company has carried before. Reuters frames the IPO as a test of whether public investors will fund the AI boom at this cost^[4].

There is a positive data point. Per Damodaran's read of the S-1, compute costs fell from more than 250% of revenue to about 48% on a quarterly basis. That is a large improvement in unit economics, and it is probably part of why the Q2 operating profit appeared. With $114B in cash and about $100B reportedly expected from the IPO, Anthropic would have years of runway even at current spending.

For buyers, capital intensity translates into three practical concerns:

• Pricing pressure: fixed compute obligations create pressure to raise revenue per customer. Expect pricing tiers and enterprise minimums to keep changing.
• Platform stability: heavy committed capacity is good for availability, but training delays like those disclosed in the S-1 can slip release timelines.
• Long-term vendor risk: a vendor with $400B+ in obligations depends on capital markets staying open. Public listing makes that dependence visible every quarter.

In short, the market prices high confidence in the listing. It has not settled whether the spending can be sustained. The IPO contracts are near-certain, the valuation contracts are split, and those two facts fit together.

What Should Developers, Founders, and SaaS Buyers Do Now?

For developers building on Claude:

• Treat a 2026 listing as the market's base case. It is not a reason to lock in further or to pull back.
• Watch the model-leadership markets before making deep, hard-to-reverse platform commitments. They can reprice within hours of a release, as Gemini 4 Carbon showed.
• Build behind an abstraction layer that lets you switch models. If one release can flip the best-model odds in 90 minutes, being able to switch has real value.

For founders raising in AI or SaaS:

• Read swings in the valuation contracts as a gauge of AI funding sentiment, not a verdict on your company. A 19-point drop in Anthropic's $2T odds suggests investors are pushing back on top-end multiples, and that discipline tends to spread to later-stage rounds.
• If your pitch compares you to Anthropic, use the Damodaran-style range and not the $2T headline.

For SaaS and enterprise buyers:

• Add the S-1's risk factors, including security incidents, training delays, and catastrophic-risk language, to your AI vendor due diligence.
• Ask about customer concentration and capacity commitments during contract negotiations. A post-IPO vendor will be under quarterly pressure that changes how it prices.
• Watch for a renegotiation window around the listing. Vendors focused on growth metrics before an IPO may be more flexible.

How to use prediction markets well, and where they fall short:

• Weight prices by volume. The $1.45M Dec 31 contract carries more signal than the $65K Nov 20 contract.
• Read the ladder as cumulative and subtract adjacent dates to find implied windows. Polymarket's companion "which month" market is a useful cross-check^[12]. Aggregators such as Polymarket Trader track the same ladder (showing Dec 31 at 94.8% at one snapshot)^[13], and Allium compares Anthropic's IPO odds with OpenAI's^[11].
• Remember what these markets measure. They capture what traders with money at stake expect. They do not measure safety, product quality, or whether a valuation is justified.

The wider takeaway for AI and SaaS: the market prices high confidence that frontier AI labs can reach public markets, and much less confidence about valuations, who leads on models, and whether the economics hold up. Your plans should account for all of those, not just the 95% figure.

Sources

^[1] Polymarket — Anthropic IPO by __? — https://polymarket.com/event/anthropic-ipo-by

^[2] TechCrunch — Anthropic officially files for its public debut — https://techcrunch.com/2026/10/26/anthropic-officially-files-for-its-public-debut/

^[3] Bloomberg — Anthropic IPO Explained: S-1 Filing, Nasdaq Listing and Key Risks — https://www.bloomberg.com/news/articles/2026-10-26/anthropic-ipo-explained-s-1-filing-nasdaq-listing-and-key-risks

^[4] Reuters — Anthropic's soaring sales, steep losses put AI frenzy to IPO test — https://www.reuters.com/legal/transactional/anthropic-opens-books-ais-explosive-growth-staggering-costs-2026-10-26/

^[5] Financial Times — Anthropic begins countdown to IPO with prospectus filing — https://www.ft.com/content/f6ecfecd-d797-4d2c-b427-d333297949cb

^[6] The Next Web — Anthropic files for Nasdaq IPO as half-year revenue hits $16.3bn — https://thenextweb.com/news/anthropic-ipo-filing-nasdaq-ant-s-1

^[7] Bloomberg — Anthropic IPO Filing Reveals $417 Billion in Future AI Spending — https://www.bloomberg.com/news/newsletters/2026-10-27/anthropic-ipo-filing-reveals-417-billion-in-future-ai-spending

^[8] CNBC — Prediction markets think Anthropic IPO near-certain in 2026 — https://www.cnbc.com/2026/10/26/prediction-markets-think-anthropic-ipo-near-certain-in-2026.html

^[9] Reuters — Prediction market bets set the tone for Anthropic's much-awaited IPO — https://www.reuters.com/legal/government/prediction-market-bets-set-tone-anthropics-much-awaited-ipo-2026-10-28/

^[10] Benzinga — Anthropic IPO: What Will ANT Stock Be Worth on Day One? — https://www.benzinga.com/markets/ipos/26/10/62595495/anthropic-ipo-ant-stock-day-one-value-polymarket

^[11] Allium — Anthropic vs OpenAI IPO Odds on Polymarket — https://allium.so/blog/anthropic-vs-openai-ipo-odds-on-polymarket/

^[12] Polymarket — In which month will Anthropic IPO? — https://polymarket.com/event/in-which-month-will-anthropic-ipo

^[13] Polymarket Trader — Anthropic IPO by __? Odds — https://polymarkettrader.com/odds/anthropic-ipo/

^[14] TechCrunch — Anthropic raises $65 billion, nears $1T valuation ahead of IPO — https://techcrunch.com/2026/05/28/anthropic-raises-65-billion-nears-1t-valuation-ahead-of-ipo/

^[15] Reuters — Anthropic raises $65 billion now valued at $965 billion — https://www.reuters.com/business/anthropic-raises-65-billion-now-valued-965-billion-2026-05-28/